You are here

First Safety Study in Humans of a Single Dose of CPG 52364

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Overland Park, Kansas, 66211 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Healthy Volunteers
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-65 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Normal body mass index and weight

- No significant diseases in the medical history or clinically significant findings on
physical exam, opthalmologic exam, clinical laboratory evaluations or 12-lead
electrocardiogram

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Current illness or history of medical condition affecting the body's function

- Use of any medication within 7 days, any immunosuppressive medication within 6 months,
any investigational drug within 30 days or any vaccine or immunoglobulin within 90
days

- Use of any medications during the study

- Positive TB test

- Smoking within 6 months

- Pregnancy or risk of Pregnancy

- Alcohol or drug misuse within 60 days

- Sensitivity to quinazolines

NCT00547014
Pfizer
Completed
First Safety Study in Humans of a Single Dose of CPG 52364

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now